Precision Vaccines Program

Thank you to the incredible panel of researchers who presented at the Immune Development in Early Life Hot Topic Symposium this weekend at Pediatric Academic Societies Meeting .

Their work highlights just how critical and dynamic early immune development is in pediatrics. By continuing to study this window, we can help improve outcomes, better understand how to shape immune responses, and drive new discoveries.

We look forward to continuing the conversation at in Minneapolis, MN, and sharing our next wave of findings in this exciting field.

From left to right: Dr. Xiaobin Wang, Dr. Ofer Levy, Dr. Oluwabunmi Olaloye, Dr. Octavio Ramilo, Dr. Paolo Palma.

Tomorrow, Sunday April 25th, Dr. Ofer Levy will chair the PAS Hot Topic Symposium: “Immune Development in Early Life (IDEAL) shapes vaccine response, respiratory infectious disease and asthma”.

The session will occur from 2:30-4:00 pm in 213 West in the Thomas M. Menino Convention & Exhibition Center. The symposium will feature presentations from leading researchers in the field followed by a Q&A session. We hope you will join us in attending this special session!

PVP director, Dr Ofer Levy, was quoted in NBC News by regarding potential changes at vaccine division.

Ophthalmologist is front-runner for next FDA vaccine chief, sources say Dr. Houman Hemmati is among "several" candidates to replace Dr. Vinay Prasad in the role.

We’re excited to share that two members of our program, Dr. Asimenia Angelidou and Dr. Sanya Thomas, will be presenting today, 16 April 2026, at ™ hosted by The American Association of Immunologists!

If attending, please join us in supporting them as they showcase their work and insights!

At the World Vaccine Congress workshop on adjuvant science; L to R: Precision Vaccines Program Director Ofer Levy; Drs. David Burkhardt (Inimmune), Wolfgang Leitner ( ), Roland Ventura Vaccine Formulation Institute), Adolfo Garcia Sastre (Icahn School of Medicine at Mount Sinai) & Ishii (The University of Tokyo / UTokyo)